Level Four Advisory Services’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-1,894
Closed -$428K 587
2020
Q2
$428K Buy
+1,894
New +$372K 0.03% 392

Other funds holding WST

Level Four Advisory Services's WST Position: Q3 2020 in Review

Level Four Advisory Services sold out of West Pharmaceutical (WST) in Q3 2020, closing a stake of 1,894 shares — an estimated $428K sold.

Level Four Advisory Services first reported a position in WST in Q2 2020 and held it in 1 quarter. The position peaked at $428K in Q2 2020. 573 funds tracked by Wall St. Rank hold WST as of Q3 2020.

  • Level Four Advisory Services reported no remaining West Pharmaceutical position as of Q3 2020 after selling out during the quarter.
  • Level Four Advisory Services sold 1,894 West Pharmaceutical shares in Q3 2020, an estimated $428K.
  • Level Four Advisory Services first reported a position in West Pharmaceutical in Q2 2020 and held it in 1 quarter.
  • Level Four Advisory Services's West Pharmaceutical position peaked at $428K in Q2 2020.
  • 573 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2020.

Based on Level Four Advisory Services's 13F filing for Q3 2020, filed 2 Nov 2020.